Mary Ashcavai

985 total citations
23 papers, 760 citations indexed

About

Mary Ashcavai is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mary Ashcavai has authored 23 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 13 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Mary Ashcavai's work include Hepatitis B Virus Studies (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis C virus research (7 papers). Mary Ashcavai is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis C virus research (7 papers). Mary Ashcavai collaborates with scholars based in United States, Taiwan and Australia. Mary Ashcavai's co-authors include Robert L. Peters, Masao Omata, Choong-Tsek Liew, Allan G. Redeker, John C. Hoefs, Henry W. Kao, Sugantha Govindarajan, Ian G. Renner, James W. Mosley and Irvin L. Schweitzer and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Mary Ashcavai

22 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ashcavai United States 16 550 475 106 86 83 23 760
P Piantino Italy 15 789 1.4× 735 1.5× 117 1.1× 144 1.7× 64 0.8× 43 1.0k
John Hodkinson South Africa 13 414 0.8× 413 0.9× 38 0.4× 82 1.0× 41 0.5× 20 565
Thung Sn United States 13 278 0.5× 223 0.5× 99 0.9× 124 1.4× 28 0.3× 34 504
Hervé Zylberberg France 15 820 1.5× 879 1.9× 73 0.7× 96 1.1× 219 2.6× 21 1.2k
Emil Miskovsky United States 15 427 0.8× 382 0.8× 34 0.3× 88 1.0× 70 0.8× 18 813
O Inoue Japan 13 909 1.7× 901 1.9× 47 0.4× 109 1.3× 34 0.4× 26 1.1k
Anne Bastie France 15 1.0k 1.9× 1.0k 2.2× 55 0.5× 75 0.9× 73 0.9× 28 1.3k
Jerrold J. Lander United States 11 426 0.8× 316 0.7× 41 0.4× 25 0.3× 77 0.9× 13 592
Thomas London United States 9 386 0.7× 285 0.6× 52 0.5× 21 0.2× 50 0.6× 10 518
H. Kumada Japan 14 879 1.6× 999 2.1× 81 0.8× 44 0.5× 80 1.0× 29 1.1k

Countries citing papers authored by Mary Ashcavai

Since Specialization
Citations

This map shows the geographic impact of Mary Ashcavai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ashcavai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ashcavai more than expected).

Fields of papers citing papers by Mary Ashcavai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ashcavai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ashcavai. The network helps show where Mary Ashcavai may publish in the future.

Co-authorship network of co-authors of Mary Ashcavai

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ashcavai. A scholar is included among the top collaborators of Mary Ashcavai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ashcavai. Mary Ashcavai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shoei‐Shen, et al.. (1989). Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.. PubMed. 84(1). 46–8. 2 indexed citations
2.
Cock, Kevin M. De, Mary Ashcavai, Sugantha Govindarajan, & Allan G. Redeker. (1987). Evaluation of anti-HBc IgM estimation by radioimmunoassay for anti-HBc on column separated IgM.. PubMed. 17(1). 27–31. 4 indexed citations
3.
Govindarajan, Sugantha, Tse–Ling Fong, & Mary Ashcavai. (1987). Concanavalin A Affinity of Alpha-Fetoprotein: Its Use in Differentiating Tumors. American Journal of Clinical Pathology. 88(6). 722–724. 10 indexed citations
4.
Kao, Henry W., Mary Ashcavai, & Allan G. Redeker. (1984). The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A†. Hepatology. 4(5). 933–936. 71 indexed citations
5.
Govindarajan, Sugantha, et al.. (1984). Evaluation of Enzyme Immunoassay for Anti-HBc IgM in the Diagnosis of Acute Hepatitis B Virus Infection. American Journal of Clinical Pathology. 82(3). 323–325. 18 indexed citations
6.
Lindsay, Karen L., Allan G. Redeker, & Mary Ashcavai. (1981). Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology. 1(6). 586–589. 26 indexed citations
7.
Govindarajan, Sugantha, Mary Ashcavai, & Robert L. Peters. (1981). α-1-antitrypsin phenotypes in hepatocellular carcinoma. Hepatology. 1(6). 628–631. 30 indexed citations
8.
Hoefs, John C., Ian G. Renner, Mary Ashcavai, & Allan G. Redeker. (1980). Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology. 79(2). 191–194. 73 indexed citations
9.
Omata, Masao, Choong-Tsek Liew, Mary Ashcavai, & Robert L. Peters. (1980). Nonimmunologic Binding of Horseradish Peroxidase to Hepatitis B Surface Antigen: A Possible Source of Error in Immunohistochemistry. American Journal of Clinical Pathology. 73(5). 626–632. 18 indexed citations
10.
Tong, Myron J., John M. Weiner, Mary Ashcavai, & Girish N. Vyas. (1979). Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer. 44(6). 2338–2342. 23 indexed citations
11.
12.
Omata, Masao, et al.. (1979). HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS MARKERS IN EUROPE AND U.S.A.. The Lancet. 313(8113). 433–434. 1 indexed citations
13.
Omata, Masao, Mary Ashcavai, Choong-Tsek Liew, & Robert L. Peters. (1979). Hepatocellular carcinoma in the U.S.A., etiologic considerations. Gastroenterology. 76(2). 279–287. 81 indexed citations
14.
Omata, Masao, Mary Ashcavai, Choong-Tsek Liew, & Robert L. Peters. (1979). Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.. PubMed. 76(2). 279–87. 94 indexed citations
15.
Omata, Masao, A. Afroudakis, Choong-Tsek Liew, Mary Ashcavai, & Robert L. Peters. (1978). Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology. 75(6). 1003–1009. 76 indexed citations
16.
Putnam, Charles W., Kendrick A. Porter, Robert L. Peters, et al.. (1977). Liver replacement for alpha1-antitrypsin deficiency.. PubMed. 81(3). 258–61. 39 indexed citations
17.
Ashcavai, Mary, et al.. (1973). Serum antitrypsin levels in acute hepatic necrosis.. BMJ. 2(5866). 616.1–616. 1 indexed citations
18.
Ashcavai, Mary & Robert L. Peters. (1971). Hepatitis-Associated Antigen: Improved Sensitivity in Detection. American Journal of Clinical Pathology. 55(3). 262–268. 20 indexed citations
19.
Peters, Robert L., et al.. (1970). AUSTRALIA (HEPATITIS) ANTIGEN IN SARCOIDOSIS. The Lancet. 296(7679). 928–928. 3 indexed citations
20.
Peters, Robert L. & Mary Ashcavai. (1970). Immunoglobulin Levels in Detection of Viral Hepatitis. American Journal of Clinical Pathology. 54(1). 102–109. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Piantino Breakdown of academic impact, for papers by John Hodkinson Breakdown of academic impact, for papers by Thung Sn Breakdown of academic impact, for papers by Hervé Zylberberg Breakdown of academic impact, for papers by Emil Miskovsky Breakdown of academic impact, for papers by O Inoue Breakdown of academic impact, for papers by Anne Bastie Breakdown of academic impact, for papers by Jerrold J. Lander Breakdown of academic impact, for papers by Thomas London Breakdown of academic impact, for papers by H. Kumada
Rankless by CCL
2026